Showing results (241-250 of 349) with videos related to
Sort By:
Pageof 35
The American Journal of Pathology|April 1, 1995
Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningiomaR Wellenreuther, J A Kraus, D Lenartz, et al.Cancer Research|October 15, 1994
Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomasL Xu, D Sgroi, C J Sterner, et al.The American Journal of Pathology|December 24, 1997
Universal absence of merlin, but not other ERM family members, in schwannomasA O Stemmer-Rachamimov, L Xu, C Gonzalez-Agosti, et al.Oncogene|June 10, 1998
PTEN mutations in gliomas and glioneuronal tumorsE M Duerr, B Rollbrocker, Y Hayashi, et al.Neuro-Oncology|April 17, 2007
Survey of treatment recommendations for anaplastic oligodendrogliomaLauren E Abrey, David N Louis, Nina Paleologos, et al.The American Journal of Pathology|July 11, 2002
Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsetsWolf Mueller, Christian Hartmann, Annegret Hoffmann, et al.Cancer Research|May 15, 1992
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytomaA von Deimling, R H Eibl, H Ohgaki, et al.Molecular Cell|July 4, 1998
The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrixM Ohh, R L Yauch, K M Lonergan, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic gliomaAllen L Ho, Matthew J Koch, Shota Tanaka, et al.Acta Neuropathologica Communications|May 1, 2019
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastomaShota Tanaka, Tracy T Batchelor, A John Iafrate, et al.Pageof 35